Literature DB >> 7033084

Bilirubin inhibits the chemotactic activity of human polymorphonuclear leukocytes in vitro.

I Miler, J Vondrácek, L Hromádková.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7033084     DOI： 10.1007/bf02927337

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN： 0015-5632            Impact factor:   2.099


× No keyword cloud information.
  13 in total

1.  Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes.

Authors:  R D Nelson; P G Quie; R L Simmons
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

Review 2.  Stimulated neutrophil locomotion: chemokinesis and chemotaxis.

Authors:  E L Becker
Journal:  Arch Pathol Lab Med       Date:  1977-10       Impact factor: 5.534

3.  [Neonatal hyperbilirubinemia. Its relation to the immunological response capacity of the newborn infant].

Authors:  E Díaz del Casrillo
Journal:  Gac Med Mex       Date:  1973-02       Impact factor: 0.302

4.  The effect of unconjugated bilirubin and some bilirubin precursors on cell culture.

Authors:  F De Ritis; F Paradisi; G Maio
Journal:  Pathol Microbiol (Basel)       Date:  1971

5.  The development of immunological factors in infants with hyperbilirubinemia.

Authors:  Z Nejedlá
Journal:  Pediatrics       Date:  1970-01       Impact factor: 7.124

6.  Effect of bilirubin on the fungicidal capacity of human neutrophils.

Authors:  Y H Thong; D Ness; A Ferrante
Journal:  Sabouraudia       Date:  1979-06

7.  Bilirubin inhibits hexose-monophosphate shunt activity of phagocytosing neutrophils.

Authors:  Y H Thong; V Rencis
Journal:  Acta Paediatr Scand       Date:  1977-11

8.  Studies of cellular toxicity of unconjugated bilirubin in kernicteric brain.

Authors:  S Schenker; D W McCandless; P E Zollman
Journal:  J Clin Invest       Date:  1966-07       Impact factor: 14.808

9.  Immune competence assessment in hyperbilirubinemic newborns before and after phototherapy.

Authors:  F F Rubaltelli; A L Piovesan; G Semenzato; A Barbato; G Ongaro
Journal:  Helv Paediatr Acta       Date:  1977-07

10.  The bactericidal activity of sera of healthy neonates and of newborns with hyperbilirubinaemia to Escherichia coli.

Authors:  I Miler; J Vondrácek; L Hromádková
Journal:  Folia Microbiol (Praha)       Date:  1979       Impact factor: 2.099
View more
  8 in total

Review 1.  The immunosuppressive effects of bilirubin.

Authors:  V Vĕtvicka; P Síma; I Miler; M Bilej
Journal:  Folia Microbiol (Praha)       Date:  1991       Impact factor: 2.099

2.  The stimulatory effect of bilirubin on phagocytic activity.

Authors:  M Bilej; V Vĕtvicka; P Síma
Journal:  Folia Microbiol (Praha)       Date:  1989       Impact factor: 2.099

3.  Interaction of bilirubin with human lymphocytes and granulocytes--the effect on bilirubin metabolism.

Authors:  E Knobloch; I Miler
Journal:  Folia Microbiol (Praha)       Date:  1986       Impact factor: 2.099

4.  The in vitro cytotoxic effect of bilirubin on human lymphocytes and granulocytes.

Authors:  I Miler; M Indrová; J Bubeník; J Vondrácek
Journal:  Folia Microbiol (Praha)       Date:  1985       Impact factor: 2.099

5.  The effect of bilirubin on the Fc receptor expression and phagocytic activity of mouse peritoneal macrophages.

Authors:  V Vĕtvicka; I Miler; P Síma; L Táborský; L Fornůsek
Journal:  Folia Microbiol (Praha)       Date:  1985       Impact factor: 2.099

6.  The effect of bilirubin on the phagocytic activity of mouse peripheral granulocytes and monocytes in vivo.

Authors:  I Miler; V Vĕtvicka; P Síma; L Táborský
Journal:  Folia Microbiol (Praha)       Date:  1985       Impact factor: 2.099

7.  Intracellular accumulation of unconjugated bilirubin inhibits phytohemagglutin-induced proliferation and interleukin-2 production of human lymphocytes.

Authors:  Y Haga; M A Tempero; D Kay; R K Zetterman
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

Review 8.  Heme Catabolic Pathway in Inflammation and Immune Disorders.

Authors:  Bing Wu; Yanwei Wu; Wei Tang
Journal:  Front Pharmacol       Date:  2019-07-24       Impact factor: 5.810
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.